MR spectroscopy study of dichloroacetate treatment after ischemic stroke

  • Glenn D. Graham
  • , P. B. Barker
  • , W. M. Brooks
  • , D. C. Morris
  • , W. Ahmed
  • , E. Bryniarski
  • , D. O. Hearshen
  • , J. A. Sanders
  • , B. A. Holshouser
  • , C. C. Turkel

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Abstract

In a double-blind, placebo-controlled study, we used 1H MR spectroscopy to assess the effect of a single infusion of sodium dichloroacetate on lesion lactate 1 to 5 days after ischemic stroke. Apparent trends toward a reduction in lactate/N-acetyl compound ratios were seen at the higher drug doses employed, and in patients treated in the first 2 days following infarction. Use of spectroscopic measures as endpoints is feasible in acute stroke clinical trials.

Original languageEnglish (US)
Pages (from-to)1376-1378
Number of pages3
JournalNeurology
Volume55
Issue number9
DOIs
StatePublished - Nov 14 2000
Externally publishedYes

ASJC Scopus subject areas

  • Clinical Neurology

Fingerprint

Dive into the research topics of 'MR spectroscopy study of dichloroacetate treatment after ischemic stroke'. Together they form a unique fingerprint.

Cite this